Guillermo Morales, Ph.D., M.B.A.
President and CEO
Dr. Morales is President and CEO of Sulfagenix, Inc. He brings 25 years of experience in chemistry and pharmaceutical R&D in positions of increasing responsibility (Director, COO, VP, CBO, CEO) for diverse research programs (early drug discovery to IND ready) and 20 years of experience in business development and strategy. He has been involved in business development, licensing, directing research and development programs, fundraising, patent and grant writing, intellectual property assessment, operations improvement, management (USA, Russia, Latin America, Asia), and financial management. Dr. Morales is the former Editor-in-Chief of the journal Molecular Diversity (11 years), has served on the editorial advisory board of several journals including Mini-Reviews in Medicinal Chemistry, Journal of Combinatorial Chemistry, and Combinatorial Chemistry & High Throughput Screening. He is the leading inventor in 9 granted patents (US and International patents, plus several applications), 36 publications (31 research articles, 2 books, and 3 book chapters), and currently serves as National Institutes of Health (NIH) Small Business Innovation Research (SBIR) Grant Reviewer.